HIV & AIDS

Revealed: Secret of HIV's natural born killers

Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

Medical research

New flu drug stops virus in its tracks

A new class of influenza drug has been shown effective against drug-resistant strains of the flu virus, according to a study led by University of British Columbia researchers.

HIV & AIDS

Is it possible to deliver a knockout punch to HIV?

With a global focus on strategies to curb expansion of a fast-moving coronavirus pandemic, the question again has arisen: What more is being done about HIV, a scourge that has lasted more than 40 years—is a cure finally ...

HIV & AIDS

Scientists see an ultra-fast movement on surface of HIV virus

As the HIV virus glides up outside a human cell to dock and possibly inject its deadly cargo of genetic code, there's a spectacularly brief moment in which a tiny piece of its surface snaps open to begin the process of infection.

HIV & AIDS

How HIV infects cells

In a long-awaited finding, an international team of scientists using high-brightness x-rays from the U.S. Department of Energy Office of Science's Advanced Photon Source at Argonne National Laboratory has determined the high-resolution ...

Diseases, Conditions, Syndromes

How the novel coronavirus binds to human cells

Coronaviruses infect humans by binding to specific proteins, known as receptors, on human cell surfaces. Researchers from the University of Minnesota, led by Professor Fang Li in the Department of Veterinary and Biomedical ...

Diseases, Conditions, Syndromes

Scientists show brain vulnerable to Hepatitis C virus

(Medical Xpress) -- Scientists at the University of Birmingham have demonstrated for the first time that human brain cells can become infected with the Hepatitis C virus (HCV), it is reported today.

Oncology & Cancer

Researchers identify key source of T cell 'exhaustion'

Custom-made to attack cancer cells, CAR T-cell therapies have opened a new era in the treatment of human cancers, particularly, in hematologic malignancies. All too often, however, they display a frustrating trait inherited ...

page 1 from 9